(19)
(11) EP 1 524 996 A2

(12)

(88) Date of publication A3:
13.05.2004

(43) Date of publication:
27.04.2005 Bulletin 2005/17

(21) Application number: 03761725.5

(22) Date of filing: 16.06.2003
(51) International Patent Classification (IPC)7A61K 45/06, A61P 9/12
(86) International application number:
PCT/IB2003/002657
(87) International publication number:
WO 2004/002461 (08.01.2004 Gazette 2004/02)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 26.06.2002 GB 0214784

(71) Applicants:
  • Pfizer Limited
    Sandwich,Kent CT13 9NJ (GB)

    GB 
  • PFIZER INC.
    New York, N.Y. 10017 (US)

    AT BE BG CH CY CZ DE DK EE ES FI FR GR HU IE IT LU MC NL LI RO SI SE TR PT SK 

(72) Inventors:
  • FOX, David Nathan Abraham
    Sadwich, Kent CT13 9NJ (GB)
  • HUGHES, Bernadette
    Sandwich, Kent CT13 9NJ (GB)

(74) Representative: Rutt, Jason Edward et al
Pfizer LimitedEuropean Patents Department,Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) COMBINATION OF PDE5 INHIBITORS WITH ANGIOTENSIN II RECEPTOR ANTAGONISTS